Revance Therapeutics Vs. Cellectar Biosciences Industry Stock Comparison

Sell

13

RVNC
Revance Therapeutics

Last Price:

$3.09

Seasonality Move:

-2.77%

Sell

37

CLRB
Cellectar Biosciences

Last Price:

$0.24

Seasonality Move:

-2.17%

Sell

13

Revance Therapeutics (RVNC) is a Sell

Is Revance Therapeutics a Buy, Sell or Hold?

The current Revance Therapeutics [RVNC] share price is $3.08. The Score for RVNC is 13, which is 74% below its historic median score of 50, and infers higher risk than normal.
RVNC is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
This Score is currently showing an extreme reading that indicates risk could be especially high.

Sell

37

Cellectar Biosciences (CLRB) is a Sell

Is Cellectar Biosciences a Buy, Sell or Hold?

The current Cellectar Biosciences [CLRB] share price is $0.24. The Score for CLRB is 37, which is 26% below its historic median score of 50, and infers higher risk than normal.
CLRB is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

RVNC Stock Price Chart

What is Revance Therapeutics's stock price today?

The Revance Therapeutics share price today is $3.08

The current trend is relatively stagnant and RVNC is experiencing slight buying pressure.

CLRB Stock Price Chart

What is Cellectar Biosciences's stock price today?

The Cellectar Biosciences share price today is $0.24

Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and CLRB is experiencing slight selling pressure.

RVNC Technical Analysis

Chart Indicators	Level	Buy or Sell
MACD (12, 26):	-0.38	Sell
Relative Strength Index (14 RSI):	33.1	Sell
Chaikin Money Flow:	0	-

Bollinger Bands	Level	Buy or Sell
Bollinger Bands (25):	(3.14 - 3.96)	Sell
Bollinger Bands (100):	(3.74 - 6.28)	Sell

CLRB Technical Analysis

Chart Indicators	Level	Buy or Sell
MACD (12, 26):	-0.43	Sell
Relative Strength Index (14 RSI):	6.1	Sell
Chaikin Money Flow:	-1047529	-

Bollinger Bands	Level	Buy or Sell
Bollinger Bands (25):	(0.52 - 1.72)	Sell
Bollinger Bands (100):	(1.33 - 2.35)	Sell

RVNC Moving Averages

Moving Averages	Level	Buy or Sell
8-day SMA:	3.07	Buy
20-day SMA:	3.46	Sell
50-day SMA:	4.37	Sell
200-day SMA:	4.37	Sell
8-day EMA:	3.14	Sell
20-day EMA:	3.46	Sell
50-day EMA:	4.1	Sell
200-day EMA:	5.56	Sell

CLRB Moving Averages

Moving Averages	Level	Buy or Sell
8-day SMA:	0.26	Sell
20-day SMA:	0.98	Sell
50-day SMA:	1.6	Sell
200-day SMA:	2.49	Sell
8-day EMA:	0.41	Sell
20-day EMA:	0.85	Sell
50-day EMA:	1.39	Sell
200-day EMA:	2.17	Sell

Revance Therapeutics Earnings Growth & RVNC Earnings Dates

Analysts estimate an earnings increase this quarter of $0.31 per share, a decrease next quarter of $0.00 per share, an increase this year of $2.38 per share, and an increase next year of $0.63 per share.

Cellectar Biosciences Earnings Growth & CLRB Earnings Dates

Analysts estimate an earnings increase this quarter of $0.17 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.26 per share, and an increase next year of $0.89 per share.

Revance Therapeutics Technical Analysis

	Dec 9	Dec 10	Dec 11	Dec 12	Dec 13	Dec 16	Dec 17	Dec 18	Dec 19	Dec 20
	Dec
	09	10	11	12	13	16	17	18	19	20
Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Cellectar Biosciences Technical Analysis

	Dec 9	Dec 10	Dec 11	Dec 12	Dec 13	Dec 16	Dec 17	Dec 18	Dec 19	Dec 20
	Dec
	09	10	11	12	13	16	17	18	19	20
Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):